Novel Arylalkenylpropargylamines as Neuroprotective, Potent, and Selective Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease

导出原文传递

翻译打印收藏纠错

作者： Huleatt, Paul B. ^[1] ; Khoo, Mui Ling ^[2] ; Chua, Yi Yuan ^[3] ; Tan, Tiong Wei ^[1] ; Liew, Rou Shen ^[4] ; Balogh, Balazs ^[2] ; Deme, Ruth ^[3] ; Goeloencser, Flora ^[3] ; Magyar, Kalman ^[3] ; Sheela, David P. ^[3] ; Ho, Han Kiat ^[5] ; Sperlagh, Beata ^[1] ; Matyus, Peter ^[3] ; Chai, Christina L. L. ^[4]

作者单位： Semmelweis Univ, Dept Organ Chem, H-1092 Budapest, Hungary ^[1] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, H-1083 Budapest, Hungary ^[2] ASTAR, Inst Chem & Engn Sci, Singapore 138665, Singapore ^[3] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore ^[4] Semmelweis Univ, Dept Pharmacodynam, H-1089 Budapest, Hungary ^[5]

发布时间 2015-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Medicinal Chemistry

2015年58卷3期

1400-1419页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Novel Arylalkenylpropargylamines as Neuroprotective, Potent, and Selective Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Novel Arylalkenylpropargylamines as Neuroprotective, Potent, and Selective Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

检索历史清除